The DOI matches its Crossref record.
Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study
Abstract
This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetic patients are at high risk of cardiovascular events, particularly of coronary heart disease by about 3-fold [67,68].”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [67]
In the citing paper
“T2DM is associated with a two-fold higher risk of CAD and ischaemic stroke”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
In the citing paper
“and a two-to four-fold higher CAD-and stroke-related mortality.139 -141”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [140]
Citations
Cited by
Sorted by citations
Items 401–500 of 999
Diabetes mellitus and arteriographically-documented coronary artery disease
Freedman, D. S., Grucho, H. W., Bamrah, V. S., Anderson, A. J., & Barboriak, J. J. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90118-7 · Cited by 33
“INTRODUCTION Autopsy [1, 2], clinical [3, 4], and prospective epidemiologic studies [5-11] indicate that diabetes mellitus confers at least a twofold increased risk for coronary heart disease (CHD) mortality.”
BackgroundResultInfluentialHypothyroidism and Cardiovascular Disease: A Review
Zúñiga, D., Balasubramanian, S., Mehmood, K. T., AL-Baldawi, S. A. A., & Salazar, G. Z. (2024) · Cureus · doi:10.7759/cureus.52512 · Cited by 46
Vazeou, A., Papadopoulou, A., Miha, M., et al. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0603-z · Cited by 32
“In contrast, other studies in adults [33, 34] and in children [35] showed increased LV dimensions in patients with T1DM.”
ResultYeh, H.-L., Kuo, L., Sung, F.-C., Chiang, C.-W., & Yeh, C. (2013) · Gene · doi:10.1016/j.gene.2013.02.052 · Cited by 31
C-Reactive Protein and Age-Related Macular Degeneration and Cataract: The Singapore Malay Eye Study
Boey, P. Y., Tay, W. T., Lamoureux, E. L., Tai, E. S., Mitchell, P., Wang, J. J., Saw, S., & Wong, T. Y. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4063 · Cited by 32
The importance of total cardiovascular risk assessment in clinical practice
Graham, I. M. (2006) · European Journal of General Practice · doi:10.1080/13814780600976282 · Cited by 32
“The presence of this clustering of risk factors predicts both an increased likelihood of developing overt diabetes and an increased risk of vascular disease of at least twofold in men and up to fourfold in women (19).”
BackgroundDiabetes and Heart Disease: An Evidence-Driven Guide to Risk Factors Management in Diabetes
Lteif, A., Mather, K., & Clark, C. (2003) · Cardiology in Review · doi:10.1097/01.crd.0000086892.07437.05 · Cited by 35
Papademetriou, V., Narayan, P., Bloomfield, H. E., Collins, D. E., & Robins, S. J. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70023-7 · Cited by 32
Neuropathic Pain, Depression, and Cardiovascular Disease: A National Multicenter Study
Cragg, J. J., Noonan, V. K., Noreau, L., Borisoff, J., & Kramer, J. K. (2015) · Neuroepidemiology · doi:10.1159/000377726 · Cited by 32
Association between Metabolic Syndrome, Smoking Status and Coronary Artery Calcification
Lee, Y.-A., Kang, S. G., Song, S.-W., Rho, J.-S., & Kim, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122430 · Cited by 32
Saraiva, R. M., Duarte, D. M., Duarte, M. P. C., et al. (2005) · Echocardiography · doi:10.1111/j.1540-8175.2005.40051.x · Cited by 31
Farrer, M., Fulcher, G. R., Albers, C., Neil, H. A. W., Adams, P. C., & Alberti, K. G. M. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90099-3 · Cited by 31
Claudi, T., Midthjell, K., Holmen, J., Fougner, K. J., Kruger, O., & Wiseth, R. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00759.x · Cited by 31
Dietary Fish Oil and Insulin Action in Humans
Heine, R. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35698.x · Cited by 29
Haffner, S. M. (1997) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(96)00099-2 · Cited by 31
Reasons for admission of individual with diabetes to the Tripoli Medical Center in 2015
Elhadi, A., & Faiza, H. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.017 · Cited by 30
Kvan, E., Pettersen, K. I., Sandvik, L., & Reikvam, A. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.003 · Cited by 30
Burut, D. F. P., Borai, A., Livingstone, C., & Ferns, G. A. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-009-0152-7 · Cited by 30
“intolerance are both important risk factors for cardiovascular disease ( Kannel and McGee 1979; Lakka et al. 2002; Tominaga et al. 1999).”
BackgroundLipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus
Siraj, E. S., Seyoum, B., Saenz, C., & Abdulkadir, J. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.002 · Cited by 30
Russell, M., Fleg, J. L., Galloway, W. J., Henderson, J. A., Howard, J., Lee, E. T., Poolaw, B., Ratner, R. E., Roman, M. J., Silverman, A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.021 · Cited by 30
Hyperglycemia, Hyperinsulinemia, Overweight, and High Blood Pressure in Young Adults
Pozzan, R., Brandão, A. A., da Silva, S. L. D., & Brandão, A. P. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.650 · Cited by 28
Treating dyslipidaemia in non-insulin-dependent diabetes mellitus — a special reference to statins
Papadakis, J. A., Milionis, H. J., Press, M., & Mikhailidis, D. P. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00139-8 · Cited by 30
Abdellatif, A., Mubarak, H., Abdellatef, H., et al. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105644 · Cited by 29
Can Genetic Pleiotropy Replicate Common Clinical Constellations of Cardiovascular Disease and Risk?
Gottesman, O., Drill, E. N., Lotay, V., Böttinger, E. P., & Peter, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046419 · Cited by 28
“Both obesity and T2D have independently and in combination, been linked with increased risk of cardiovascular disease and death [1,2,3].”
BackgroundZhang, D., Zhang, X., Liu, D., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0362-0 · Cited by 29
“The increased prevalence of low platelet inhibition following clopidogrel treatment and twofold to fourfold increased risk of cardiovascular disease were found in diabetes mellitus (DM) patients compared with non-DM patients [4–9].”
BackgroundDu, R., Zhang, R., Lu, L., Shen, Y. H., Pu, L. J., Zhu, Z. B., Zhang, Q., Hu, J., YANG, Z. K., Ding, F. H., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0792-y · Cited by 28
Ghafarian, F., Pashirzad, M., Khazaei, M., Rezayi, M., Hassanian, S. M., Ferns, G. A., & Avan, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27964 · Cited by 30
“(2) Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran (3) Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK (4) Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran (5) Department o…”
BackgroundThambiah, S. C., & Lai, L. C. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00248 · Cited by 35
“Following the Framingham Study, diabetes became an established cardiovascular disease (CVD) risk factor [2].”
MethodInfluentialSex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension
Li, C., Engström, G., Hedblad, B., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239287.10013.e0 · Cited by 29
Taki, H., Kashiwagi, A., Tanaka, Y., et al. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00151-8 · Cited by 29
Schinkel, A. F. L., Elhendy, A. A., van Domburg, R. T., Bax, J. J., Vourvouri, E. C., Sozzi, F. B., Valkema, R., Roelandt, J. R. T. C., & Poldermans, D. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1637 · Cited by 29
Itoh, M., Omi, H., Okouchi, M., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00219-7 · Cited by 29
Lerstad, G., Brodin, E. E., Enga, K. F., Jorde, R., Schirmer, H., Njølstad, I., Svartberg, J. B., Brækkan, S. K., & Hansen, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12498 · Cited by 29
Li, H., Ge, Y., Zhang, L., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.03.041 · Cited by 28
Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?
Kennedy, M., Fabris, E., Suryapranata, H., & Kedhi, E. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0533-7 · Cited by 27
Okayama, N., Omi, H., Okouchi, M., et al. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00178-2 · Cited by 28
Appropriate Blood Pressure Control in Type II Diabetes (ABCD Trial): Implications for Complications
Schrier, R. W., & Savage, S. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70236-6 · Cited by 28
Malfitano, C., Barboza, C. D. A., Mostarda, C. T., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0131-x · Cited by 28
“The predisposing factors in diabetes are associated with a two – to four – fold increased risk of coronary heart disease [3].”
BackgroundEdwards, I. J., Wagner, J. D., Vogl-Willis, C. A., Litwak, K. N., & Cefalu, W. T. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-6 · Cited by 28
Ischemia Imaging and Plaque Imaging in Diabetes
Raggi, P., Bellasi, A., & Ratti, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2787 · Cited by 28
Diet as preventive medicine in cardiology
de Lorgeril, M., & Salen, P. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200009000-00009 · Cited by 28
Leósdóttir, M., Willenheimer, R. B., Persson, M., & Nilsson, P. M. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-118 · Cited by 27
Peter, I., McCaffery, J. M., Kelley-Hedgepeth, A., Hakonarson, H. H., Reís, S. E., Wagenknecht, L. E., Kopin, A. S., Huggins, G. S., & Study, F. T. G. S. O. T. L. A. (2012) · Obesity · doi:10.1038/oby.2012.11 · Cited by 27
Insulin Resistance and Atherosclerosis
Raghavan, V. A. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.014 · Cited by 27
Hsu, C.-S., Chiu, W., & Yeh, S. L. (2003) · Nutrition Research · doi:10.1016/s0271-5317(02)00386-x · Cited by 27
Diabetic microangiopathy, genetics, environment, and treatment.
Siperstein, M. D. (1988) · American Journal of Medicine · doi:10.1016/0002-9343(88)90404-4 · Cited by 28
Blood glucose and risk of coronary heart disease.
Ostrander, L. D., Lamphiear, D. E., Carman, W. J., & Williams, G. W. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.1.33 · Cited by 27
Impaired glucose tolerance and risk factors for atherosclerosis.
Vaccaro, O., Rivellese, A. A., Riccardi, G., Capaldo, B., Tutino, L., Annuzzi, G., & Mancini, M. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.6.592 · Cited by 27
de Santiago, A., García‐Lledó, A., Ramos, E., et al. (2007) · Revista Española de Cardiología · doi:10.1157/13111235 · Cited by 26
Cardiovascular risk factors in developing countries: A review of clinico-epidemiological evidence
Prasad, D. S., Kabir, Z., Dash, A. K., & Das, B. (2010) · Global Heart · doi:10.1016/j.cvdpc.2010.09.001 · Cited by 26
“Diabetes or a low high-density lipoprotein (HDL) cholesterol abolish the advantage of women over men in terms of risk for CAD [59].”
BackgroundRusso, G. T., Giandalia, A., Romeo, E. L., Marotta, M., Alibrandi, A., Francesco, C. D., Horvath, K. V., Asztalos, B. F., & Cucinotta, D. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0023-z · Cited by 26
“Women generally have a *10 year-delay in the onset of cardiovascular events as compared to men; however, diabetes seems to eliminate this ‘gender-advantage’, with diabetic women showing even a higher risk for coronary heart disease (CHD) than diabetic men [1–5].”
BackgroundAnagnostis, P. G., Majeed, A., Johnston, D. G., & Godsland, I. F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0401 · Cited by 26
Decreased Lipid Peroxidation Following Periodontal Therapy in Type 2 Diabetic Patients
Sonoki, K., Nakashima, S., Takata, Y., et al. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.060088 · Cited by 26
Fatema, K., Zwar, N. A., Milton, A. H., Rahman, B., & Ali, L. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008140 · Cited by 26
Determination of personalized diabetes treatment plans using a two-delay model
Kissler, S. M., Cichowitz, C., Sankaranarayanan, S., & Bortz, D. M. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.06.005 · Cited by 27
“ronic high levels of glucose in the blood, which can lead to peripheral neuropathy, cardiovascular disease, blindness, and even death (American Diabetes Association [2], Boulton [7], Kannel and Mcgee [18]). Type I diabetes is caused by autoimmune attack on the insulin-producing pancreatic β-cells. Its onset is largely…”
BackgroundScreening for traditional risk factors for cardiovascular disease
Glick, M. (2002) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2002.0168 · Cited by 26
Silent coronary artery disease in patients with diabetes mellitus
Zellweger, M. J., & Pfisterer, M. E. (2001) · Swiss Medical Weekly · doi:10.4414/smw.2001.09749 · Cited by 26
“The overall prevalence of CAD among patients with diabetes is higher than in non-diabetic patients and may be as high as 55% among patients with diabetes [ 1 ].”
BackgroundResultMetabolic risk factors for coronary heart disease: current and future prospects
Wilson, P. W. F. (1999) · Current Opinion in Cardiology · doi:10.1097/00001573-199903000-00016 · Cited by 25
Coronary heart disease risk factors in older persons
Corti, M. C., Guralnik, J. M., & Bilato, C. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339560 · Cited by 25
Pronóstico de los pacientes diabéticos con cardiopatía isquémica
Zamora, A., & Marrugat, J. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76694-3 · Cited by 25
Ahnadi, C.-E., Masmoudi, T., Berthezène, F., & Ponsin, G. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00791.x · Cited by 26
Comprehensive Geriatric Assessment in the Management of Older Patients With Cardiovascular Disease
Singh, M., Spertus, J. A., Gharacholou, S. M., Arora, R. C., Widmer, R. J., Kanwar, A., Sanjanwala, R., Welle, G. A., & Al-Hijji, M. A. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.09.003 · Cited by 25
Brucellosis in Dairy Cattle and Goats in Northern Ecuador
Poulsen, K. P., Hutchins, F. T., McNulty, C. M., Tremblay, M., Zabala, C., Barragán, V., Lopez, L., Trueba, G. A., & Bethel, J. W. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0362 · Cited by 25
Imazu, M., Sumii, K., Yamamoto, H., et al. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00016-5 · Cited by 25
“Several prospective studies [3,4,11] have reported that the relative risk of diabetes was an independent risk factor for cardiovascular mortality in both genders.”
BackgroundBemelmans, R. H. H., Wassink, A. M. J., van der Graaf, Y., Nathoe, H. M., Vernooij, J. W. P., Spiering, W., & Visseren, F. L. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1017 · Cited by 25
Aso, Y., Okumura, K., Yoshida, N., Tayama, K., Kanda, T., Kobayashi, I., Takemura, Y., & Inukai, T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01058.x · Cited by 25
Tentolouris, A., Eleftheriadou, I., Athanasakis, K., Kyriopoulos, J. E., Tsilimigras, D. I., Grigoropoulou, P., Doupis, J., & Tentolouris, N. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.04.008 · Cited by 26
Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors
Gale, C. P., Futers, T. S., & Summers, L. K. M. (2004) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2004.004 · Cited by 25
Thor, M., Yu, A., & Swedenborg, J. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00037-3 · Cited by 25
“Since the prevalence of cardiovascular disease is increased in patients with diabetes [10,11], it is possible that”
BackgroundMortality Among Type 2 Diabetic Individuals and Associated Risk Factors: The Three City Study
Sprafka, J. M., Pankow, J. S., McGovern, P. C., & French, L. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00135.x · Cited by 25
Tian, L., Long, S., Li, C., Liu, Y., Chen, Y., Zeng, Z., & Fu, M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-54 · Cited by 24
“It has been reported that adults with diabetes are at a 2- to 4-fold increased risk of CAD events relative to those without DM [1-5] and are at about 60% increased risk of early mortality [6].”
BackgroundDiabetic vascular disease and the potential role of macrophage glucose metabolism
Nishizawa, T., & Bornfeldt, K. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.585346 · Cited by 24
van Herpt, T. T. W., Lemmers, R. F. H., van Hoek, M., Langendonk, J. G., Erdtsieck, R. J., Bravenboer, B., Lucas, A. E. M., Mulder, M. T., Haak, H. R., Lieverse, A. G., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0245-x · Cited by 25
Diabetic foot complications: a two-year review of limb amputation in a Kelantanese population.
Yusof, M. I., Sulaiman, A. R., & Muslim, D. A. J. (2007) · PubMed · Cited by 24
Prevalence of major cardiovascular risk factors among oil and gas and energy company workers.
Mannocci, A., Pignalosa, S., Saulle, R., et al. (2015) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_15_02_13 · Cited by 24
“Some risk factors such as family history, ethnicity and age, cannot be changed, other risk factors that can be prevented, changed or treated include tobacco exposure, harmful use of alcohol, unhealthy diets and obesity, physical inactivity, stress, high blood pressure (hypertension), diabetes and dyslipidemia [5-10].”
BackgroundDietary soy prevents brain Na+, K+-ATPase reduction in streptozotocin diabetic rats
Franzon, R. C., Chiarani, F., Mendes, R. H., Belló‐Klein, A., & Wyse, Â. T. D. S. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.010 · Cited by 24
Chen, H.-F., & Li, C. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.05.020 · Cited by 24
“As the risks of coronary artery disease are higher in diabetic patients [3–7], the risks associated”
BackgroundResultG Protein-Linked Cell Signaling and Cardiovascular Functions in Diabetes/Hyperglycemia
Hashim, S., Li, Y., & Anand‐Srivastava, M. B. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:051 · Cited by 24
“An increased rate of thrombosis and accelerated atherogenesis in patients with diabetes mellitus also has been reported (1,2).”
BackgroundRaskin, P., Ganda, O. P., Schwartz, S. L., Willard, D. A., Rosenstock, J., Lodewick, P. A., Cressman, M. D., Phillipson, B., Weiner, B. H., McGovern, M. E., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80182-x · Cited by 24
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 23
Wasan, K. M., Ng, S. P.-Y., Wong, W., & Rodrigues, B. B. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01464.x · Cited by 22
Russo, G. T., Benedetto, A. D., Alessi, E., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345540 · Cited by 23
Candasamy, M., Murthy, T. E. G. K., Gubiyappa, K., et al. (2014) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.139728 · Cited by 23
Predicting the Risk of Cardiovascular Comorbidities in Adult Cancer Survivors
Tashakkor, A. Y., Moghaddamjou, A., Chen, L. Y. C., & Cheung, W. Y. (2013) · Current Oncology · doi:10.3747/co.20.1470 · Cited by 23
“1 Sex Men 382 (42) 436 (31) 11,682 (49) Women 379 (58) 654 (69) 12,655 (51) Ethnicity White 492 (85) 787 (89) 11,707 (75) Black 137 (9) 158 (7) 4,958 (12) Hispanic 111 (7) 120 (4) 6,693 (13) Education Less than high school 206 (24) 271 (22) 6,410 (20) High school 167 (28) 232 (29) 4,681 (26) More than high school 259…”
McGillicuddy, F. C., & Roche, H. M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100785 · Cited by 23
“Indeed, certain chronic inflammatory conditions also predispose to the development of CAD including insulin resistance (IR) [18], type 2 diabetes mellitus [19] and arthritis [20].”
BackgroundTanwar, O., Tanwar, L., Shaquiquzzaman, M., Alam, M. M., & Akhter, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.076 · Cited by 23
Abbasi, M., Neishaboury, M., Koohpayehzadeh, J., Etemad, K., Meysamie, A., Asgari, F., Noshad, S., Afarideh, M., Ghajar, A., Ganji, M., et al. (2018) · Global Heart · doi:10.1016/j.gheart.2018.01.001 · Cited by 23
“A cluster of cardiometabolic risk factors has been attributed to the development of arteriosclerosis and CHD, namely the components of central obesity, hyperglycemia, dyslipidemia, and hypertension, the combination ofwhich is characterized as metabolic syndrome [7-9].”
BackgroundHung, W., Wang, C.-P., Lu, L.-F., Yu, T., Chiu, C., Chung, F., Chen, H., Houng, J., Shin, S., & Lee, Y. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-020 · Cited by 23
Kitano, Y., Kasuga, H., Watanabe, M., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.037 · Cited by 23
Janghorbani, M., Jones, R. B., Gilmour, W. H., Hedley, A. J., & Zhianpour, M. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90161-9 · Cited by 23
Watanabe, J., Kobayashi, K., Umeda, F., Yamauchi, T., Mimura, K., Nakashima, N., Masakado, M., Hiramatsu, S., & Nawata, H. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90018-z · Cited by 24
Perera, M. (2002) · Human Reproduction · doi:10.1093/humrep/17.2.497 · Cited by 22
“Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes”
BackgroundLei, M., Wu, Y., Chung, S., Chen, C.-C., Chen, W.-C., & Hsu, Y.-C. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.59386 · Cited by 22
CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy
Veitch, C. R., Power, A., & Erickson, J. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695401 · Cited by 23
Poulsen, M., Henriksen, J., Dahl, J., Johansen, A., Møller, J., Gerke, O., Vach, W., Haghfelt, T., Beck-Nielsen, H., & Høilund-Carlsen, P. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9118-5 · Cited by 25
Review: Pre-diabetes: clinical relevance and therapeutic approach
Pratley, R. E., & Matfin, G. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070030401 · Cited by 22
Nova abordagem para o tratamento da diabetes: da glicemia à doença cardiovascular
Aguíar, C., Duarte, R., & Carvalho, D. M. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2018.03.013 · Cited by 22
Host and environmental interactions in diabetes mellitus
Orchard, T. J., Dorman, J. S., LaPorte, R. E., et al. (1986) · Journal of Chronic Diseases · doi:10.1016/0021-9681(86)90135-9 · Cited by 22
Age threshold for vascular prophylaxis by aspirin in patients without diabetes
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., Fernando, D., & Idris, I. (2008) · Heart · doi:10.1136/hrt.2008.150698 · Cited by 21
Which diabetic patients should be taking aspirin?
Yudkin, J. S. (1995) · BMJ · doi:10.1136/bmj.311.7006.641 · Cited by 22
“How can this be extrapolated to patients with diabetes? Diabetes is an independent risk factor for cardiovascular disease, increasing the risk twofold to threefold in men and postmenopausal women and around fivefold in premenopausal women.”
Background
Metadata
- Authors
- Kannel, W. B., & McGee, D. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1979-03-01
- Volume
- 2
- Issue
- 2
- Pages
- 120-126
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059537042
- Cited by
- 1,203
- References
- 0
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
- MeSH terms
- Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review